What are the symptoms of aortic stenosis?

The classic triad of symptomatic severe aortic stenosis is: chest pain on exertion (angina), shortness of breath on exertion that progresses to rest, and syncope (fainting or near-fainting), particularly with exertion. Once any of these symptoms appear in the context of severe AS, the median survival without valve replacement is 2 to 3 years. Symptoms mandate urgent evaluation.

How common is aortic stenosis in men?

Aortic stenosis is the most common valvular heart disease requiring intervention in developed countries. Prevalence increases sharply with age: approximately 2 to 3 percent of adults over 65 have moderate to severe AS, rising to approximately 10 percent in men over 85.

What is TAVR for aortic stenosis?

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that replaces the diseased aortic valve through a catheter inserted in the femoral artery, without open-chest surgery. TAVR has become the dominant treatment for severe AS in high and intermediate-risk patients and is now approved for low-risk patients as well.

How is cardiovascular risk calculated?

The ACC/AHA Pooled Cohort Equation estimates 10-year cardiovascular risk using age, sex, race, total cholesterol, HDL, systolic blood pressure, treatment status, diabetes, and smoking. A 10-year risk above 7.5 percent generally supports preventive statin therapy. Risk-enhancing factors including coronary artery calcium score, ApoB, high-sensitivity CRP, and adverse pregnancy history can modify the decision in borderline-risk patients. The calculator should be used as a starting point for shared decision-making, not a binary treatment threshold.

What lifestyle changes have the largest cardiovascular benefit?

Smoking cessation provides the largest single modifiable risk reduction, reducing cardiovascular events by 30 to 50 percent within years of quitting. Regular aerobic exercise reduces all-cause cardiovascular mortality by 20 to 30 percent in prospective cohort data. Blood pressure control in hypertensive patients reduces stroke risk by 35 to 40 percent. Dietary approaches reducing saturated fat, sodium, and refined carbohydrates while increasing vegetables, legumes, and fish reduce cardiovascular risk across multiple metabolic pathways simultaneously.

The Vascular Clock

Aortic Stenosis in Men. What the Murmur Means and When the Valve Needs Replacing.

Aortic stenosis is the most common valvular disease in men over 65. A cardiologist explains the symptom triad and the TAVR decision.

Job Mogire, MD, FACP, FACC · Medically reviewed June 14, 2026

A man in his late sixties comes in for a routine visit. His wife says he has slowed down on walks. He attributes it to being out of shape. The echocardiogram done for an unrelated murmur shows a valve area of 0.9 cm2 and a mean gradient of 48 mmHg. He has severe aortic stenosis, and the symptom he is minimizing is not deconditioning. It is exertional dyspnea from a failing valve.

The Mechanism

Aortic stenosis is the progressive narrowing of the aortic valve opening. The aortic valve sits between the left ventricle and the aorta, and it normally opens to 2.5 to 3.5 cm2 with each heartbeat to allow unrestricted forward flow. In calcific aortic stenosis, calcium deposits accumulate on the valve leaflets over decades, progressively stiffening and restricting that opening. The result is obstruction to the outflow of blood from the heart with every beat.

The biology of this process overlaps substantially with atherosclerosis. Oxidized lipoproteins deposit on the aortic side of the valve leaflets. Inflammatory cells infiltrate. Osteoblast-like cells differentiate within the valve tissue and drive calcification in a process that resembles, but is not identical to, bone formation. Risk factors for calcific aortic stenosis track closely with those for coronary artery disease: age, male sex, hypertension, hyperlipidemia, diabetes, and smoking all accelerate valve calcification. The shared risk factor profile explains why the two conditions commonly coexist. 5 / Solid

A bicuspid aortic valve, present in approximately 1 to 2 percent of the population and significantly more common in men, compresses the timeline dramatically. The abnormal mechanical stress on a two-leaflet valve accelerates calcium deposition. Men with bicuspid aortic valves can develop severe aortic stenosis 10 to 20 years earlier than those with the normal three-leaflet configuration. A bicuspid valve identified at any age is a reason for lifelong echocardiographic surveillance.

The left ventricle responds to the obstruction with concentric hypertrophy, thickening its walls to generate the higher pressures needed to push blood through the narrowed valve. This adaptation is initially effective. The ventricle maintains stroke volume and cardiac output for years, sometimes decades, through this compensatory mechanism. But the adaptation has a ceiling. As the stenosis progresses, the pressure load eventually exceeds what even a hypertrophied ventricle can sustain, and left ventricular function begins to decline. When it does, the clinical course accelerates.

What the Evidence Shows

The natural history of aortic stenosis has been understood for decades in broad terms, though its quantification has sharpened with modern echocardiography and large registry data.

The disease progresses through three categories of increasing severity based on echocardiographic parameters: mild (valve area above 1.5 cm2), moderate (1.0 to 1.5 cm2), and severe (below 1.0 cm2). The rate of progression from moderate to severe averages a loss of approximately 0.1 cm2 per year, though this varies substantially between individuals, and some patients progress much faster. 5 / Solid

The landmark natural history paper by Ross and Braunwald, published in Circulation in 1968, established the prognostic framework that still guides clinical decision-making. Their analysis of unoperated patients showed that once symptomatic, the median survival was approximately two years for patients presenting with heart failure, three years for those presenting with syncope, and five years for those presenting with angina alone. (Ross and Braunwald, 1968, Circulation) These numbers have held up across subsequent observational cohorts. Symptom onset in severe aortic stenosis is a near-emergency.

The PARTNER trial series established the evidence base for transcatheter aortic valve replacement across risk categories. PARTNER 1, published in the New England Journal of Medicine in 2011, enrolled high-surgical-risk patients with severe symptomatic aortic stenosis and randomized them to TAVR or surgical aortic valve replacement. TAVR was non-inferior to surgery for all-cause mortality at one year, with similar stroke rates and a significantly shorter recovery. (Leon et al., NEJM, 2011)

PARTNER 2 and the SURTAVI trial extended the evidence to intermediate-risk patients, again showing non-inferiority of TAVR to surgery for mortality outcomes. PARTNER 3 and the Evolut Low Risk trial were the pivotal studies in low-surgical-risk patients. PARTNER 3 showed TAVR was actually superior to surgery for the primary composite endpoint of death, stroke, or rehospitalization at one year: 8.5 percent for TAVR versus 15.1 percent for surgery. (Mack et al., NEJM, 2019) 5 / Solid

These trials transformed clinical practice. TAVR is now the most commonly performed valve replacement procedure in the United States for severe aortic stenosis. The catheter-based approach avoids open-chest surgery, cardiopulmonary bypass, and cardiac arrest, and it permits valve replacement in patients who are too high-risk for conventional surgery.

Important caveats on TAVR: valve durability data at 10 years and beyond are still accumulating. Current evidence shows good performance through 5 to 7 years, but longer-term comparisons with surgical bioprostheses are not yet fully available. For men under 65 with low surgical risk and expected longevity exceeding 20 years, this durability uncertainty is a reason some heart teams still favor surgical valve replacement with a tissue valve, or discuss the mechanical valve option in younger patients. These decisions require individualized heart team discussion.

The RECOVERY trial, published in the New England Journal of Medicine in 2021, addressed the timing question in asymptomatic severe aortic stenosis. Patients with asymptomatic severe AS were randomized to early surgical AVR versus standard watchful waiting with surgery triggered by symptom development. Early intervention reduced the combined outcome of operative mortality and cardiovascular death by 74 percent. (Kang et al., NEJM, 2020) This trial has shifted the debate about whether to wait for symptoms in truly severe disease, particularly in younger, lower-risk patients.

The echocardiogram is the cornerstone of aortic stenosis staging and surveillance. Key parameters that define severity include valve area (severe when below 1.0 cm2), mean pressure gradient across the valve (severe when above 40 mmHg), and peak aortic jet velocity (severe when above 4 m/s). Left ventricular ejection fraction is tracked as a marker of myocardial decompensation. A declining ejection fraction in severe aortic stenosis signals that the ventricle is failing under the pressure load, and it escalates the urgency of intervention substantially.

A specific entity worth knowing is “low-flow, low-gradient” aortic stenosis: patients with severe AS but low gradients because left ventricular function has declined significantly. These patients can appear to have less severe disease by gradient criteria when in fact they have the most severe form. They require careful hemodynamic evaluation, sometimes including dobutamine stress echocardiography, to sort out true severity. 5 / Solid

Cardiologist's Note

The most common presentation I encounter is a man who has been followed for “mild to moderate” aortic stenosis for several years without symptoms. He comes in now mentioning that he gets winded climbing stairs where he used to run them. On echocardiography, his valve area has dropped from 1.4 cm2 to 0.85 cm2, and his mean gradient has risen significantly above the severe threshold. He minimized the symptom for months, attributing it to being less active or gaining weight.

The critical point is that symptom onset has already moved his situation from surveillance to referral. The interval between when the symptom began and when he mentioned it costs time that the prognosis data says he cannot afford. In my experience, men in particular minimize exertional symptoms and attribute them to other causes. The clinical teaching from the natural history data is that when a man with known severe aortic stenosis develops any exertional symptom that is new, that symptom warrants contact with a cardiologist this week, not at the next scheduled visit.

I also see a parallel error at the other end: the asymptomatic patient with a valve area of 0.9 cm2 who is followed indefinitely with no discussion of timing. The RECOVERY trial has changed that conversation. For the right patient, particularly a younger man with low surgical risk and a valve in the truly severe range, early intervention before symptom onset is now a reasonable and evidence-supported discussion. The waiting-for-symptoms strategy was the standard because we lacked trial data on early intervention. We now have some of that data.

For patients considering TAVR versus surgery, my general framing is this: if you are 75 and your anatomy is suitable, TAVR is almost certainly the right choice. If you are 52 and otherwise healthy, the durability question matters enough that you and your surgeon need to have an honest conversation about what a second procedure in 15 years looks like, and whether a surgical approach now avoids that calculus. There is no single right answer. The answer depends on age, anatomy, risk, and what the patient understands about the trade-offs.

Bicuspid Aortic Valve: A Distinct Disease in Men

Roughly 1 to 2 percent of the population is born with a bicuspid aortic valve, a congenital abnormality in which the valve has two leaflets instead of the normal three. The condition has a striking male predominance: it occurs approximately three times more often in men than in women. This means that for men presenting with significant aortic stenosis before age 65, bicuspid aortic valve is a common underlying cause, not a rare finding.

The clinical significance of a bicuspid valve extends beyond the valve itself. The abnormal geometry places asymmetric mechanical stress on the valve leaflets with every heartbeat, accelerating the calcium deposition that drives stenosis. Severe aortic stenosis in a man with a bicuspid valve can develop in his fifties, sometimes his forties, compared with the typical seventh or eighth decade for calcific stenosis on a normal three-leaflet valve. This compressed timeline has practical implications: a man diagnosed with a bicuspid valve at age 40 during evaluation for a murmur needs to understand he is not on the same natural history curve as the typical AS patient, and his surveillance schedule should reflect that.

The aortic root problem is distinct from the valve problem and is frequently underappreciated. Bicuspid aortic valve is associated with abnormal connective tissue in the aortic root and ascending aorta, independent of any hemodynamic effects from the valve itself. Men with bicuspid valves are at meaningfully elevated risk for aortic root dilation and ascending aortic aneurysm, even if their valve function is currently normal. The mechanism involves intrinsic abnormalities in the extracellular matrix of the aortic wall that cause it to enlarge over time. This aortic disease can progress silently and reach dimensions where dissection risk becomes clinically significant. 5 / Solid

Guidelines from the American College of Cardiology and American Heart Association specify that men with bicuspid aortic valve should have their aortic root and ascending aorta measured by echocardiography at the time of diagnosis. If the maximal aortic diameter is less than 4.5 cm and valve disease is mild, surveillance imaging is recommended every 3 to 5 years or more frequently if there is a family history of aortic dissection or if prior imaging showed rapid progression. When dimensions approach or exceed 5.0 to 5.5 cm, surgical consultation for prophylactic aortic repair is indicated even if the valve itself has not yet required intervention. The thresholds in specific guidelines vary, and the precise cutoff for any individual should be established with a cardiologist experienced in aortic disease.

The inheritance pattern of bicuspid aortic valve is another reason it warrants dedicated attention. First-degree relatives of a patient with a bicuspid valve have approximately a 9 percent risk of also having the condition. For a man who learns at age 50 that his aortic stenosis stems from a bicuspid valve, this finding has implications for his sons, brothers, and father. Echocardiographic screening of first-degree relatives is a reasonable and guideline-supported discussion. A family history of aortic dissection in the setting of bicuspid valve substantially elevates the individual risk assessment.

When bicuspid aortic valve requires valve replacement, the surgical anatomy is more complex than for a standard tricuspid valve. Many patients with bicuspid AS also have aortic root or ascending aortic enlargement that may need to be addressed at the same operation. This makes the surgical planning conversation particularly important. TAVR is anatomically feasible in many patients with bicuspid valves, but the asymmetric leaflet configuration presents greater technical challenges, and outcomes data specific to bicuspid anatomy from the major TAVR trials are more limited than for the standard tricuspid population. Some structural heart programs approach bicuspid TAVR with different considerations than tricuspid cases, and center experience matters here. 4 / Promising

Activity, Exercise, and the Spectrum of Aortic Stenosis Severity

One of the most practically important and frequently mishandled questions in aortic stenosis management is the exercise question. It does not have a single answer. It has an answer that depends on where the patient sits on the severity spectrum and whether symptoms are present.

For men with mild to moderate aortic stenosis and no symptoms, regular physical activity is not only permitted but beneficial. Cardiovascular fitness matters for long-term outcomes in this population, and there is no evidence that moderate aerobic exercise accelerates valve progression or precipitates adverse events. Walking, cycling at moderate intensity, swimming, and light resistance training are generally appropriate. High-intensity competitive athletics represent a different and more individualized discussion, but recreational fitness activity should not be reflexively restricted in an asymptomatic man with mild or moderate AS.

Exercise stress testing is an underutilized tool in this population that can add meaningful information. An asymptomatic man who reports he feels fine may, on formal stress testing, develop exertional hypotension, abnormal blood pressure response, or significant ST changes at modest workloads. Any of these findings reclassifies him into a higher-risk category even without overt symptoms. Current guidelines support exercise testing in truly asymptomatic patients with severe aortic stenosis to help identify those who may benefit from earlier intervention. The point is not to provoke symptoms dangerously but to unmask the hemodynamic limits that the valve is imposing at higher demand states. Exercise testing should be performed in appropriate supervised clinical settings. 4 / Promising

The picture changes substantially for severe aortic stenosis, and most dramatically when symptoms are present. The pathophysiology explains why: a severely narrowed valve creates a fixed outflow obstruction. Under resting conditions, the hypertrophied ventricle can sustain cardiac output. But with exertion, the heart rate increases and the demand for cardiac output rises sharply. The stenotic valve cannot increase its effective opening area to accommodate the increased flow demand. The result is that cardiac output fails to rise appropriately with exercise, coronary perfusion may become inadequate even without epicardial coronary disease, and the ventricle is exposed to extreme pressure loads. Sudden cardiac death from severe symptomatic aortic stenosis, though not common, occurs in this setting of hemodynamic stress from exertion.

For a man with confirmed severe aortic stenosis and any of the classic symptoms, strenuous exertion is not appropriate, and the clinical conversation should shift entirely toward valve replacement, not activity modification. The symptoms define the threshold. A man who develops angina, syncope, or significant dyspnea on exertion in the context of severe AS is already in the danger zone that the natural history data quantifies: median survival without intervention is measured in two to three years.

For the man with severe aortic stenosis who is truly, rigorously asymptomatic, which should be confirmed with careful history and ideally with exercise testing, light to moderate activity can generally be continued while the timing of intervention is being planned. Competitive athletics and vigorous exertion at the upper ranges of capacity are discouraged in severe AS regardless of symptom status. The practical guidance is that activities which are comfortable, do not provoke symptoms, and remain below the intensity level that causes hemodynamic stress are generally acceptable as a bridge to planned intervention, with the understanding that intervention is the goal, not indefinite activity management.

What to Do This Week

If you have been told you have a heart murmur and have not had an echocardiogram in the past three to five years, ask your physician whether one is appropriate. Not all murmurs are aortic stenosis, but the ones that are require periodic monitoring.
If you have known aortic stenosis of any severity and have developed any new exertional symptoms, including shortness of breath, chest discomfort, or near-fainting, do not minimize them or wait for your next scheduled follow-up. Contact your cardiologist this week. The natural history data on symptom onset is specific: delay matters.
If you have a bicuspid aortic valve, confirm that you are on a regular echocardiographic surveillance schedule. A bicuspid valve without significant stenosis now can develop severe stenosis in a decade. The surveillance interval should be established with your cardiologist based on your current valve area and rate of prior progression.
If you have severe aortic stenosis and have been told you can watch and wait, ask your cardiologist to walk you through the RECOVERY trial findings and what they mean for your specific situation. The conversation about early versus delayed intervention has changed with recent trial data.
If you have severe aortic stenosis that requires intervention, request evaluation at a center with a dedicated structural heart disease program. The volume-outcome relationship in both TAVR and surgical aortic valve replacement is well-documented. High-volume centers have better procedural outcomes, and the decision between TAVR and surgery benefits from a multidisciplinary heart team with experience across both approaches.

The man who acts on new exertional symptoms promptly, who keeps his surveillance schedule, and who asks his cardiologist specific questions about timing and approach is the man whose aortic stenosis gets managed before it becomes a crisis. The natural history of this disease is predictable. The point of that predictability is that it permits planning.

Start with the gap between how you appear and what your body is doing.

Take the Signal Check

Did this land?

The conversation

Join the men working through this in the open.